A groundbreaking gene therapy trial has successfully restored hearing in individuals with a rare form of congenital deafness. Researchers delivered a functional OTOF gene via a single injection, enabling speech recognition in some patients within weeks. This marks a significant shift towards correcting the root cause of genetic hearing loss.
